| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.00095 | 1 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.00059 | 1 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.00051 | 1 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.0005 | 1 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.00071 | 1 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.00047 | 1 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.00053 | 1 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00018 | 1 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.00016 | 1 |